Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices

被引：2
|
作者：
Abed, Inga [1 ]
Gonzalez-Quevedo, Rosa [1 ]
Mura, Manuela [2 ]
Dias, Monica [3 ]
da Rocha Dias, Silvy [4 ]
Garcia Burgos, Juan [1 ]
机构：
[1] European Med Agcy, Publ & Stakeholders Engagement, Amsterdam, Netherlands
[2] European Med Agcy, Hlth Threats & Vaccines Strategy, Amsterdam, Netherlands
[3] European Med Agcy, Supply & Avilbil Med & Devices, Regulatory Sci & Innovat Task Force, Amsterdam, Netherlands
[4] European Med Agcy, Expert Panels & Groups, Committees & Qual Assurance, Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2023年 / 89卷 / 01期
关键词：
D O I：
10.1111/bcp.15567
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5 / 10
页数：6
相关论文
共 13 条
  • [1] THE EUROPEAN MEDICINES AGENCY: A PUBLIC HEALTH EUROPEAN AGENCY?
    Mahalatchimy, Aurelie
    Rial-Sebbag, Emmanuelle
    De Grove-Valdeyron, Nathalie
    Tournay, Virginie
    Cambon-Thomsen, Anne
    Duguet, Anne-Marie
    Taboulet, Florence
    MEDICINE AND LAW, 2012, 31 (01): : 25 - 42
  • [2] Preparing Europe for future health threats and crises - the European Medicines Agency; ensuring safe and effective medicines and medical devices
    Cooke, Emer
    EUROSURVEILLANCE, 2022, 27 (42)
  • [3] Enhancing Vulnerable Groups' Participation in Medicines Risk Regulation: The Case of the European Medicines Agency's Public Hearing on Quinolone Antibiotics
    Wood, Matthew
    EUROPEAN JOURNAL OF RISK REGULATION, 2023, 14 (02) : 332 - 350
  • [4] EU health solidarity in times of crisis: explaining public preferences towards EU risk pooling for medicines
    Baute, Sharon
    de Ruijter, Anniek
    JOURNAL OF EUROPEAN PUBLIC POLICY, 2022, 29 (08) : 1183 - 1205
  • [5] Health horizons: Future trends and technologies from the European Medicines Agency's horizon scanning collaborations
    Vignali, Valentina
    Hines, Philip A.
    Cruz, Ana Gloria
    Zietek, Barbara
    Herold, Ralf
    FRONTIERS IN MEDICINE, 2022, 9
  • [6] Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments-A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment
    Berntgen, Michael
    Gourvil, Anne
    Pavlovic, Mira
    Goettsch, Wim
    Eichler, Hans-Georg
    Kristensen, Finn Borlum
    VALUE IN HEALTH, 2014, 17 (05) : 634 - 641
  • [7] Can independent regulatory agencies mend Europe's democracy? The case of the European Medicines Agency's public hearing on Valproate
    Wood, Matthew
    BRITISH JOURNAL OF POLITICS & INTERNATIONAL RELATIONS, 2022, 24 (04): : 607 - 630
  • [8] Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council
    Elias, Liberatus
    Mushi, Lawrencia
    BMC HEALTH SERVICES RESEARCH, 2024, 24 (01)
  • [9] Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council
    Liberatus Elias
    Lawrencia Mushi
    BMC Health Services Research, 24
  • [10] Is it necessary to modify the normative of medical research when drugs are not the study objective? Response from the Spanish Agency of Medicines and Health Devices
    de la Fuente Honrubia, Cesar
    Macias Saint-Gerons, Diego
    Montero Corominas, Dolores
    MEDICINA CLINICA, 2012, 138 (12): : 546 - 547
12